N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2013

Mikhail S Novikov, and Vladimir T Valuev-Elliston, and Denis A Babkov, and Maria P Paramonova, and Alexander V Ivanov, and Sergey A Gavryushov, and Anastasia L Khandazhinskaya, and Sergey N Kochetkov, and Christophe Pannecouque, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini, and Katherine L Seley-Radtke
Department of Pharmaceutical & Toxicological Chemistry, Volgograd State Medical University, Pavshikh Bortsov Sq., 1, Volgograd 400131, Russia.

A series of phenyloxyethyl and cinnamyl derivatives of substituted uracils were synthesized and found to exhibit potent activity against HIV-RT and HIV replication in cell culture. In general, the cinnamyl derivatives proved superior to the phenyloxyethyl derivatives, however 1-[2-(4-methylphenoxy)ethyl]-3-(3,5-dimethylbenzyl)uracil (19) exhibited the highest activity (EC(50)=0.27 μM) thus confirming that the 3-benzyluracil fragment in the NNRTI structure can be regarded as a functional analogue of the benzophenone pharmacophore typically found in NNRTIs.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002934 Cinnamates Derivatives of cinnamic acid (the structural formula: phenyl-HC Cinnamate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014498 Uracil One of four nucleotide bases in the nucleic acid RNA.
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse

Related Publications

Mikhail S Novikov, and Vladimir T Valuev-Elliston, and Denis A Babkov, and Maria P Paramonova, and Alexander V Ivanov, and Sergey A Gavryushov, and Anastasia L Khandazhinskaya, and Sergey N Kochetkov, and Christophe Pannecouque, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini, and Katherine L Seley-Radtke
January 1996, Biochemistry,
Mikhail S Novikov, and Vladimir T Valuev-Elliston, and Denis A Babkov, and Maria P Paramonova, and Alexander V Ivanov, and Sergey A Gavryushov, and Anastasia L Khandazhinskaya, and Sergey N Kochetkov, and Christophe Pannecouque, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini, and Katherine L Seley-Radtke
June 2009, Journal of medicinal chemistry,
Mikhail S Novikov, and Vladimir T Valuev-Elliston, and Denis A Babkov, and Maria P Paramonova, and Alexander V Ivanov, and Sergey A Gavryushov, and Anastasia L Khandazhinskaya, and Sergey N Kochetkov, and Christophe Pannecouque, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini, and Katherine L Seley-Radtke
February 1992, AIDS research and human retroviruses,
Mikhail S Novikov, and Vladimir T Valuev-Elliston, and Denis A Babkov, and Maria P Paramonova, and Alexander V Ivanov, and Sergey A Gavryushov, and Anastasia L Khandazhinskaya, and Sergey N Kochetkov, and Christophe Pannecouque, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini, and Katherine L Seley-Radtke
January 1996, Methods in enzymology,
Mikhail S Novikov, and Vladimir T Valuev-Elliston, and Denis A Babkov, and Maria P Paramonova, and Alexander V Ivanov, and Sergey A Gavryushov, and Anastasia L Khandazhinskaya, and Sergey N Kochetkov, and Christophe Pannecouque, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini, and Katherine L Seley-Radtke
November 2006, PLoS pathogens,
Mikhail S Novikov, and Vladimir T Valuev-Elliston, and Denis A Babkov, and Maria P Paramonova, and Alexander V Ivanov, and Sergey A Gavryushov, and Anastasia L Khandazhinskaya, and Sergey N Kochetkov, and Christophe Pannecouque, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini, and Katherine L Seley-Radtke
March 2010, Bioorganic & medicinal chemistry letters,
Mikhail S Novikov, and Vladimir T Valuev-Elliston, and Denis A Babkov, and Maria P Paramonova, and Alexander V Ivanov, and Sergey A Gavryushov, and Anastasia L Khandazhinskaya, and Sergey N Kochetkov, and Christophe Pannecouque, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini, and Katherine L Seley-Radtke
March 2010, Bioorganic & medicinal chemistry letters,
Mikhail S Novikov, and Vladimir T Valuev-Elliston, and Denis A Babkov, and Maria P Paramonova, and Alexander V Ivanov, and Sergey A Gavryushov, and Anastasia L Khandazhinskaya, and Sergey N Kochetkov, and Christophe Pannecouque, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini, and Katherine L Seley-Radtke
October 1997, AIDS clinical care,
Mikhail S Novikov, and Vladimir T Valuev-Elliston, and Denis A Babkov, and Maria P Paramonova, and Alexander V Ivanov, and Sergey A Gavryushov, and Anastasia L Khandazhinskaya, and Sergey N Kochetkov, and Christophe Pannecouque, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini, and Katherine L Seley-Radtke
October 2018, European journal of medicinal chemistry,
Mikhail S Novikov, and Vladimir T Valuev-Elliston, and Denis A Babkov, and Maria P Paramonova, and Alexander V Ivanov, and Sergey A Gavryushov, and Anastasia L Khandazhinskaya, and Sergey N Kochetkov, and Christophe Pannecouque, and Graciela Andrei, and Robert Snoeck, and Jan Balzarini, and Katherine L Seley-Radtke
February 1995, Science (New York, N.Y.),
Copied contents to your clipboard!